NasdaqGM:ODDPersonal Products
Is Oddity’s (ODD) METHODIQ Telehealth Launch Changing Its Long-Term Growth Strategy?
Oddity Tech Ltd. recently reported third quarter results with sales rising to US$147.9 million and net income of US$17.75 million, alongside the launch of METHODIQ, a telehealth platform targeting dermatology care.
In addition to delivering solid earnings growth and raising its full-year revenue outlook, Oddity is signaling a significant move into digital healthcare with METHODIQ, potentially widening its long-term addressable market.
We'll take a look at how the METHODIQ launch creates new...